Ann Malester

District of Columbia

District of Columbia Bar

Since 1977

Partner

Weil, Gotshal & Manges LLP

Current

Current

Olympus Corporation Acquisition of Gyrus Group by Olympus Corp Represented Olympus Corporation, a maker of imaging systems, medical systems (including endoscopes), and life science products, in its $1.9 billion purchase of Gyrus Group Plc, a manufacturer of endoscopes and other medical devices.

Current

Goldman Sachs Capital Partners Acquisition of Alltel Corporation Antitrust counsel for Goldman Sachs Capital Partners regarding the $27.5 billion acquisition of wireless phone company Alltel by GS Capital Partners and TPG Capital. Obtained clearance from the DOJ without a Request for Additional Information.

Current

Johnson & Johnson Obtained clearance for Johnson & Johnson's attempted acquisition of Guidant Obtained clearance under both the US HSR Act and the EU merger control regulation for Johnson & Johnson in its attempted $20+ billion acquisition of Guidant Corporation

Current

Johnson & Johnson Johnson & Johnson's acquisition of Pfizer's Consumer healthcare and OTC drug business Provided Johnson & Johnson with antitrust counsel in its $16.6 billion acquisition of Pfizer's Consumer healthcare and OTC drug business. Obtained clearance with limited divestitures given the scope of the transaction.

Current

Vanguard Car Rental Acquisition by Enterprise Rent-A-Car of Vanguard Car Rental including National and Alamo Represented Vanguard Car Rental in the sale of its National Car Rental and Alamo Rent A Car businesses to Enterprise Rent-A-Car. Antitrust clearance was obtained for this merger of two of the five national rental car companies without a Second Request.

George Washington University

J.D.

1977

Bryn Mawr College

B.A.

1973

District of Columbia Bar

Member

1977 - Current

Antitrust Considerations in Negotiating and Preparing for a Merger (Westin Hotel, Washington, DC, September 17, 2007) Ann Malester will be speaking at the Antitrust in Healthcare program, co-sponsored with the ABA’s Health Law Section and Section of Antitrust Law. Ann will be a panelist on Monday, September 17 at 1:50 p.m.

Current Developments in Antitrust Policy Affecting M&A (New York Hilton HotelNew York, June 10, 2005) Ann will be speaking at the IBA's 4th International Mergers and Acquisitions Conference which is being held in New York at the Hilton Hotel, June 9 - 10, 2005. Ann's panel is at 10:30 AM on Friday, June 10 and is titled "Current Developments In Antitrust Policy Affecting M & A." "The panel will discuss recent developments in antitrust and competition policy, including recent cases (eg Blockbuster/Hollywood and BMG/Sony) and assessments as to the future direction of antitrust policy."

Drug and Device Firm Mergers (Hotel Monaco, Washington DCHotel Monaco, Washington DC, May 12, 2005) Ann Malester will be speaking at the "Antitrust in Healthcare" conference being held in Washington DC, at the Hotel Monaco. Ann's panel titled "Drug and Device Firm Mergers," is at 8:30 a.m. on Friday, May 13.

Merger Enforcement (New York, March 03, 2004) Speaking at the Antitrust Conference Board.

Innovation Markets (Washington DC, February 18, 2004) Panelist at the FTC Workshop on the Horizontal Merger Guidelines.